Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

First Patient Dosed in QBiotics & MSD Clinical Trial Collaboration for Unresectable Melanoma

prnasiaJune 03, 2021

Tag: QBiotics , msd , tigilanol tiglate , pembrolizumab

PharmaSources Customer Service